Skip to main content
For US Healthcare Professionals Only
Quick Links
Prescribing Information
BIMZELX® (bimekizumab-bkzx)
CIMZIA® (certolizumab pegol)
RYSTIGGO® (rozanolixizumab-noli)
ZILBRYSQ® (zilucoplan)
Adverse Event Reporting
Report an Adverse Event or Product Complaint
Email
1-844-599-CARE (2273)
Connect with an MSL
Connect With Us
Main navigation
Home
Our Science
Publications
Clinical Pipeline
Opportunities for Investigators
Disease Education
Dermatology
Rare Disease
Rheumatology
Podcasts
Congress Materials
Medical Information
Slide Library
HCP Resources
Prescribing Information
Connect With an MSL
Connect With Us
BIMZELX® (bimekizumab-bkzx)
CIMZIA® (certolizumab pegol)
RYSTIGGO® (rozanolixizumab-noli)
ZILBRYSQ® (zilucoplan)
Home
Congress Materials
American Academy of Neurology (AAN), 2024
Characteristics, Treatment Patterns and Disease Burden of Juvenile Myasthenia Gravis in the United States
< Back to search results
Characteristics, Treatment Patterns and Disease Burden of Juvenile Myasthenia Gravis in the United States
View PDF
Download
For US Healthcare Professionals Only
For US Healthcare Professionals Only